# Oral Dosage Form New Animal Drugs; Monensin
> **Food and Drug Administration** · Final rule. · Published 1998-02-11 · Effective 1998-02-23 · 63 FR 6862
## Document
- **Document number:** 98-3355
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 63 FR 6862
- **CFR reference:** 21 CFR 520
- **Publication date:** 1998-02-11
- **Effective date:** 1998-02-23
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of two supplemental new animal drug applications (NADA's) filed by Elanco Animal Health, Division of Eli Lilly & Co. The supplemental NADA's provide for transferring the data and information in one NADA into another and withdrawing approval of the vacated NADA. The NADA's provide for use of monensin Type A medicated articles to make a free-choice Type C medicated feed/mineral granules for pastured cattle for increased rate of weight gain.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/1998/02/11/98-3355/oral-dosage-form-new-animal-drugs-monensin)
---
*AI Analytics · CC0 1.0*